Recommended

Register now: Enhancing biopharma workflows with the power of UV/Vis spectroscopy webinar
Download our brand new eBook: A practical guide to single-use filtration in biopharma.
Join us as we look at how the outsourcing of buffers is helping biopharma drug manufacturers to streamline their processes.
Learn more about leveraging real-world data, the practical applications of AI and adopting configurable LC/NC solutions.
Download this compendium to discover how hot-melt extrusion can help to overcome pharmaceutical formulation challenges
Join this webinar to hear about the latest RMM technology and how it aligns with UPS testing criteria.

List view / Grid view

Francis Cuss

 

Bristol Myers Squibb logo
Bristol Myers Squibb logo
news

Bristol-Myers Squibb receives complete Response Letter from U.S. Food and Drug Administration for daclatasvir, an investigational treatment for Hepatitis C

Bristol-Myers Squibb Company announced that the U.S. Food and Drug…

27 November 2014 | By Bristol-Myers Squibb

Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration has issued a Complete Response Letter regarding the New Drug Application for daclatasvir, an NS5A complex inhibitor, in combination with other agents for the treatment of hepatitis C...

Bristol Myers Squibb logo
Bristol Myers Squibb logo
news

Bristol-Myers Squibb continues to lead the advancement of immuno-oncology with broad set of new data at 2014 American Society of Clinical Oncology Annual Meeting

Bristol-Myers Squibb Company announced that new data from studies investigating…

6 May 2014 | By Bristol-Myers Squibb Company

Bristol-Myers Squibb Company announced that new data from studies investigating its immunotherapies in adjuvant and advanced melanoma, non-small cell lung cancer and metastatic renal cell carcinoma will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology...